Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 12:13:763110.
doi: 10.3389/fnagi.2021.763110. eCollection 2021.

The Potential Role of miRNAs in Cognitive Frailty

Affiliations
Review

The Potential Role of miRNAs in Cognitive Frailty

Giulia Carini et al. Front Aging Neurosci. .

Abstract

Frailty is an aging related condition, which has been defined as a state of enhanced vulnerability to stressors, leading to a limited capacity to meet homeostatic demands. Cognitive impairment is also frequent in older people, often accompanying frailty. Age is the main independent risk factor for both frailty and cognitive impairment, and compelling evidence suggests that similar age-associated mechanisms could underlie both clinical conditions. Accordingly, it has been suggested that frailty and cognitive impairment share common pathways, and some authors proposed "cognitive frailty" as a single complex phenotype. Nevertheless, so far, no clear common underlying pathways have been discovered for both conditions. microRNAs (miRNAs) have emerged as key fine-tuning regulators in most physiological processes, as well as pathological conditions. Importantly, miRNAs have been proposed as both peripheral biomarkers and potential molecular factors involved in physiological and pathological aging. In this review, we discuss the evidence linking changes of selected miRNAs expression with frailty and cognitive impairment. Overall, miR-92a-5p and miR-532-5p, as well as other miRNAs implicated in pathological aging, should be investigated as potential biomarkers (and putative molecular effectors) of cognitive frailty.

Keywords: MCI (mild cognitive impairment); biomarkers; cognitive frailty; cognitive impairment; frailty; miRNA–microRNA.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
miRNAs in frailty and cognitive deficits. miRNAs play a major role in RNA silencing and post-transcriptional regulation of gene expression. miRNAs target hundreds of transcripts to regulate various biological pathways and processes, repressing translation or inducing mRNA degradation of target transcripts through sequence-specific binding. miRNAs are key modulators of almost all physiological processes and, consequently, miRNA dysregulation is seen in a multiplicity of diseases, including frailty and cognitive deficits.
FIGURE 2
FIGURE 2
Common mechanisms underlying frailty and cognitive deficits. The high majority of mechanisms known to be involved in frailty were also implicated in cognitive diseases, including oxidative stress, inflammaging, mitochondrial dysfunction, cellular senescence, neuroendocrine dysfunctions, and impaired neuronal plasticity.

References

    1. Alvarez-Garcia I., Miska E. A. (2005). MicroRNA functions in animal development and human disease. Development 132 4653–4662. 10.1242/dev.02073 - DOI - PubMed
    1. Ardeljan A. D., Hurezeanu R. (2021). Sarcopenia. Treasure Island, FL: StatPearls Publishing. - PubMed
    1. Azpurua J., Eaton B. A. (2015). Neuronal epigenetics and the aging synapse. Front. Cell Neurosci. 9:208. 10.3389/fncel.2015.00208 - DOI - PMC - PubMed
    1. Basak I., Patil K. S., Alves G., Larsen J. P., Moller S. G. (2016). microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases. Cell Mol. Life Sci. 73 811–827. 10.1007/s00018-015-2093-x - DOI - PMC - PubMed
    1. Beard J. R., Officer A., de Carvalho I. A., Sadana R., Pot A. M., Michel J. P., et al. (2016). The World report on ageing and health: a policy framework for healthy ageing. Lancet 387 2145–2154. 10.1016/S0140-6736(15)00516-4 - DOI - PMC - PubMed